Harvard Bioscience
HBIO
HBIO
80 hedge funds and large institutions have $109M invested in Harvard Bioscience in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
Holders
80
Holding in Top 10
2
Calls
$71K
Puts
–
Top Buyers
| 1 | +$1.98M | |
| 2 | +$1.72M | |
| 3 | +$1M | |
| 4 |
GPC
Glacier Peak Capital
Bellevue,
Washington
|
+$844K |
| 5 |
TA
Teton Advisors
Rye,
New York
|
+$772K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$1.08M | |
| 3 | -$455K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$196K |
| 5 |
Renaissance Technologies
New York
|
-$184K |